Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Discovery Diabetes

for
Type 1 Diabetes
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 13 - 21

Code: NCT07116434

Recruiting

Abatacept for the Treatment of Giant Cell Arteritis

for
Giant Cell Arteritis
Location: Nashville TN, Cleveland OH, Rochester MN, Toronto,
Sponsor: University of Pennsylvania

Sex: All

Age: 50+

Code: NCT04474847

Phase 3, Recruiting
New

A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity

for
Obesity or Overweight
Location: Nashville TN, Anniston AL, Port Orange FL
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07843498

Phase 3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Nashville TN, Chattanooga TN, Louisville KY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase 3, Recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

for
Non-small Cell Lung Cancer,
Location: Nashville TN, Pittsburgh PA, Jacksonville FL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05877599

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation

for
Solid Tumors
Location: Nashville TN, St Louis MO, Cleveland OH, Houston TX,
Sponsor: Jacobio Pharmaceuticals Co., Ltd.

Sex: All

Age: 18+

Code: NCT06386146

Phase 1, Phase 2, Recruiting

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for
Transthyretin Amyloidosis, ATTR-CM, ATTRv-PN, ATTR, ATTR-Mixed,
Location: Nashville TN, Germantown TN, Greenville SC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06465810

Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for
Non-Small Cell Lung Cancer
Location: Nashville TN, Atlanta GA, Lexington KY, Carterville IL,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT06767514

Phase 3, Recruiting

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

for
Overweight, Prediabetic State, Prehypertension,
Location: Nashville TN, Dalton GA, Knoxville TN, Anniston AL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07794579

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Migraine
Location: Nashville TN, Chattanooga TN, Bardstown KY,
Sponsor: Kallyope Inc.

Sex: All

Age: 18 - 70+

Code: NCT07645924

Phase 3, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Nashville TN, Atlanta GA, Macon GA, Indianapolis IN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase 3, Recruiting

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

for
Urothelial Cancer, Bladder Cancer
Location: Nashville TN, Peoria IL, Chapel Hill NC, Niles IL,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07129993

Phase 2, Phase 3, Recruiting

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Acute Migraine
Location: Nashville TN, Chattanooga TN, Bardstown KY,
Sponsor: Kallyope Inc.

Sex: All

Age: 18+

Code: NCT07674654

Phase 3, Recruiting

DESTINY-PANTUMOUR04

for
Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer,
Location: Nashville TN, Birmingham AL, Decatur IL, Durham NC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07124000

Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for
Untreated Follicular Lymphoma
Location: Nashville TN, Huntsville AL, Macon GA, Charlotte NC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06549595

Phase 3, Recruiting

Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

for
Migraine
Location: Nashville TN, Memphis TN, City of Saint Peters MO,
Sponsor: Aspeya, Inc.

Sex: All

Age: 18 - 65

Code: NCT07646613

Phase 2, Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for
Prostate Cancer
Location: Nashville TN, Newnan GA, Greenwood IN, Columbus OH,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT06952803

Phase 3, Recruiting

Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Nashville TN, St Louis MO, East Providence RI
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07427394

Phase 2, Recruiting

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

for
Non-small Cell Lung Cancer, Colorectal Carcinoma,
Location: Nashville TN, St Louis MO, Chicago IL, Pittsburgh PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06218914

Phase 1, Recruiting

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)

for
Multiple Myeloma
Location: Nashville TN, Atlanta GA, St Louis MO,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07073547

Phase 1, Recruiting